Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients

被引:0
作者
Diana Carmona-Fernandes
Maria José Santos
Inês Pedro Perpétuo
João Eurico Fonseca
Helena Canhão
机构
[1] Instituto de Medicina Molecular,Rheumatology Research Unit
[2] Faculdade de Medicina da Universidade de Lisboa,Rheumatology Department
[3] Edifício Egas Moniz,Rheumatology and Bone Metabolic Diseases Department
[4] Hospital Garcia de Orta,undefined
[5] Hospital de Santa Maria,undefined
来源
Arthritis Research & Therapy | / 13卷
关键词
sRANKL; osteoprotegerin; systemic lupus erythematosus; osteoclastogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 146 条
[1]  
Santos MJ(2009)Predictors of damage progression in Portuguese patients with systemic lupus erythematosus Ann N Y Acad Sci 1173 822-828
[2]  
Vinagre F(2009)Osteoporosis in patients with systemic lupus erythematosus Isr Med Assoc J 11 486-491
[3]  
Nero P(2006)Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus Nat Clin Pract Rheumatol 2 562-569
[4]  
Barcelos F(2005)Bone health and systemic lupus erythematosus Curr Rheumatol Rep 7 482-489
[5]  
Barcelos A(2010)The importance of inflammation and vitamin D status in SLE-associated osteoporosis Autoimmun Rev 9 137-139
[6]  
Rodrigues AM(2010)Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases -- a case-control study with 53,108 patients with fracture J Rheumatol 37 2247-2250
[7]  
de Matos AA(2005)Rheumatic diseases: the effects of inflammation on bone Immunol Rev 208 228-251
[8]  
Silva C(2009)Bone health in systemic lupus erythematosus Curr Rheumatol Rep 11 177-184
[9]  
Miranda L(2010)Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion Arthritis Res Ther 12 R164-64
[10]  
Capela S(2007)Biology of RANK, RANKL, and osteoprotegerin Arthritis Res Ther 9 S1-495